Show Summary Details
Page of

Lupus nephritis: Complement in lupus 

Lupus nephritis: Complement in lupus
Chapter:
Lupus nephritis: Complement in lupus
Author(s):

Michael G. Robson

DOI:
10.1093/med/9780199579655.003.0024
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 05 August 2020

1. A consideration of the complement system is important to those caring for patients with lupus, and for those seeking to understand the pathogenesis.

2. Low levels of C3 or C4, and anti-C1q antibodies are markers of disease activity in lupus. C1q antibodies are correlated with nephritis, but can occur without renal disease in a significant number of patients.

3. Normal levels of C3, C4 and anti-C1q antibodies strongly suggest clinically inactive disease, although abnormal levels may occur with both inactive and active disease.

4. Deposition of complement components in renal and skin biopsy tissue is characteristic of lupus.

5. Although the complement system has well documented proinflammatory functions, the evidence suggests that these may not be an essential part of the effector mechanisms causing tissue damage in lupus. However, the situation is not straightforward, and a proinflammatory role for complement is suggested by some experimental data.

6. Deficiencies of the early classical pathway are strongly associated with lupus, suggesting a protective role for complement. This may be due to defective clearance of immune complexes and/or apoptotic cells leading to increased autoantigen availability, and/or to effects on mechanisms of immunological tolerance.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.